- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04021446
A Supervised Clinic-to-Community Exercise Intervention to Improve Cardiometabolic Health in Survivors of AYA Cancer (ASCEND)
September 27, 2021 updated by: Christina Dieli-Conwright, University of Southern California
A Supervised Clinic-to-Community Exercise Intervention to Improve Cardiometabolic Health in Survivors of Adolescent and Young Adult Cancer: The ACSEND Trial
The main goal of this clinical trial is to use a novel exercise intervention to improve cardiometabolic and biopsychosocial health outcomes in overweight/obese sedentary survivors of AYA cancers at risk for chronic comorbid conditions.
The investigator's hypothesis is that an exercise intervention will improve: cardiometabolic health; body composition; physical fitness and biopsychosocial outcomes when compared to the attention control group.
Study Overview
Status
Withdrawn
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 39 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- AYA cancer survivors (18-39) Must be 12 months after treatment No metastatic disease
Exclusion Criteria:
- Metastatic disease Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Exercise
Will receive the exercise intervention
|
personalized exercise prescription
|
NO_INTERVENTION: Attention Control
Will not receive the exercise intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiometabolic health - Insulin Resistance
Time Frame: change from baseline to 4 months, to 8 months to 1 year
|
insulin resistance estimated by HOMA from a fasting blood sample
|
change from baseline to 4 months, to 8 months to 1 year
|
Cardiometabolic health - metabolic syndrome waist circumference
Time Frame: change from baseline to 4 months, to 8 months to 1 year
|
markers of metabolic syndrome, waist circumference via measuring tape (cm)
|
change from baseline to 4 months, to 8 months to 1 year
|
Cardiometabolic health - metabolic syndrome blood pressure
Time Frame: change from baseline to 4 months, to 8 months to 1 year
|
markers of metabolic syndrome, blood pressure via Omron cuff (mmHg)
|
change from baseline to 4 months, to 8 months to 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body Composition
Time Frame: change from baseline to 4 months, to 8 months to 1 year
|
fat mass and lean mass via DEXA (reported in lbs)
|
change from baseline to 4 months, to 8 months to 1 year
|
Cardiorespiratory fitness (Physical Fitness)
Time Frame: change from baseline to 4 months, to 8 months to 1 year
|
cardiorespiratory fitness via submaximal VO2 max (reported via ml/kg/min)
|
change from baseline to 4 months, to 8 months to 1 year
|
Muscular Strength (Physical Fitness)
Time Frame: change from baseline to 4 months, to 8 months to 1 year
|
muscle strength through multiple repetition maximum (lbs)
|
change from baseline to 4 months, to 8 months to 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
September 1, 2019
Primary Completion (ANTICIPATED)
September 1, 2023
Study Completion (ANTICIPATED)
September 1, 2024
Study Registration Dates
First Submitted
March 12, 2019
First Submitted That Met QC Criteria
July 12, 2019
First Posted (ACTUAL)
July 16, 2019
Study Record Updates
Last Update Posted (ACTUAL)
September 29, 2021
Last Update Submitted That Met QC Criteria
September 27, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- AYA_ASCEND
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Body Composition
-
Nova Southeastern UniversityCompleted
-
Centro Universitario de Ciencias de la Salud, MexicoCompleted
-
University of Southern CaliforniaCompleted
-
University of California, San FranciscoHologic, Inc.Completed
-
University of SurreyUnknownBody Composition
-
Texas Woman's UniversityCompleted
-
Auburn UniversityCompletedBody CompositionUnited States
-
Universidad de ZaragozaUnknown
-
University Hospital, Clermont-FerrandCenter of study in Human Nutrition, INRA, Department of Clinical NutritionCompleted
-
Samsung Medical CenterEnrolling by invitationBody Composition | RemimazolamKorea, Republic of
Clinical Trials on Exercise
-
University of Kansas Medical CenterRecruiting
-
National Institute of Neurological Disorders and...TerminatedTraumatic Brain InjuryUnited States
-
University of Texas, El PasoRecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain SyndromeUnited States
-
Bayero University Kano, NigeriaCompletedChronic Low Back PainNigeria
-
University of Alabama at BirminghamCompletedCystic FibrosisUnited States
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
Center for Health, Exercise and Sport Sciences,...CompletedSedentary LifestyleSerbia
-
Heitor Moreno JuniorUnknown
-
Middle East Technical UniversityCompletedOsteoarthritis | Degenerative Lesion of Articular Cartilage of Knee | Articular Cartilage Disorder of KneeTurkey
-
University of LisbonFundação para a Ciência e a TecnologiaActive, not recruiting